Loading data
BHVNNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 635.07 m USD | 795.87 m USD | 373.28 m USD | 437.07 m USD | 181.49 m USD |
| Operating profit | -745.38 m USD | -885.11 m USD | -436.05 m USD | -567.93 m USD | -218.9 m USD |
| Profit before tax | -737.38 m USD | -845.69 m USD | -409.55 m USD | -569.84 m USD | -212.43 m USD |
| Income tax expense | 1.44 m USD | 735 k USD | -1.38 m USD | 438 k USD | 1.37 m USD |
| Net income (reported basis) | -739 USD | -846 USD | -408 USD | -570 USD | -213.8 m USD |
| Basic earnings per share | -6.86 USD/share | -9.28 USD/share | -5.73 USD/share | -12.75 USD/share | -5.43 USD/share |
| Diluted earnings per share | -6.86 USD/share | -9.28 USD/share | -5.73 USD/share | -12.75 USD/share | -5.43 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.